Olink announces participation in November investor events

Rhea-AI Summary

Olink Holding AB (Nasdaq: OLK) has announced participation in two key investor events in November 2021. The first is a virtual investor day on November 15, featuring discussions with leading experts on ongoing research projects and Olink's commercial strategy. The second event is the Nordic Post IPO Seminar 2021, where CFO Oskar Hjelm will present on November 24. Olink aims to advance proteomics through its collaborations in academia and biopharma, enhancing understanding of human biology and contributing to modern healthcare solutions.

Positive

• Participation in a virtual investor day allows for direct engagement with key opinion leaders.
• The presence at the Nordic Post IPO Seminar enhances visibility among investors.

Negative

• None.

UPPSALA, Sweden, Nov. 05, 2021 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK), today announced that it will be participating in two investor events in November.

Olink virtual investor day with proteomics KOLs
On November 15th, 2021, from 12:30pm to 3:30pm ET (6:30pm to 9:30pm CET), Olink will host a virtual investor day, providing direct access to key opinion leaders from leading universities and BioPharma companies, discussing exciting research projects where Olink is a proud contributor, while also providing an overview of Olink’s commercial plans.

Nordic Post IPO Seminar 2021
Oskar Hjelm, CFO, will participate in the Nordic Post IPO Seminar 2021, on November 24^th, from 4:00am to 4:45am ET (10:00am to 10:45 am CET) hosted by Handelsbanken Capital Markets.

About Olink
Olink Holding AB (Nasdaq: OLK) is a company dedicated to accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients. Olink provides a platform of products and services which are deployed across major biopharmaceutical companies and leading clinical and academic institutions to deepen the understanding of real-time human biology and drive 21st century healthcare through actionable and impactful science. The company was founded in 2016 and is well established across Europe, North America and Asia. Olink is headquartered in Uppsala, Sweden.

Olink IR Contact
Jan Medina, CFA
VP Investor Relations & Capital Markets
Mobile: +1 617 802 4157
jan.medina@olink.com

Olink Media Contact
Andrea Prander
Corporate Communications Manager
Mobile: + 46 768 775 275
andrea.prander@olink.com

FAQ

What events is Olink (OLK) participating in November 2021?

Olink will participate in a virtual investor day on November 15 and the Nordic Post IPO Seminar on November 24, 2021.

What topics will be discussed at Olink's virtual investor day?

The virtual investor day will cover exciting research projects and Olink's commercial plans, featuring key opinion leaders from academia and biopharma.

Who is presenting at the Nordic Post IPO Seminar for Olink?

CFO Oskar Hjelm will represent Olink at the Nordic Post IPO Seminar on November 24, 2021.

How does Olink contribute to healthcare?

Olink accelerates proteomics research aimed at improving patient outcomes through partnerships with major biopharmaceutical companies and academic institutions.